全麻剖宫产后阿片节省多模式镇痛:美国729家医院回顾性队列研究
该回顾性队列研究基于Premier数据库,纳入2008至2018年间18岁以上全麻剖宫产患者130,946例,评估阿片节省多模式镇痛(osMMA)的使用情况。结果显示osMMA使用率为8.5%,从2008年2.0%升至2018年18.8%,但整体仍偏低;黑人种族和西班牙裔与较低使用率相关,医院间变异中等(ICC=38%)。
要点
- 全麻剖宫产后osMMA使用率仅8.5%,2018年升至18.8%但仍不理想。
- 黑人种族和西班牙裔患者接受osMMA的几率更低。
- 医院间osMMA使用变异中等(ICC=38%),需关注术后镇痛实践。
核心结论
- 全麻剖宫产后osMMA使用率低但呈上升趋势,存在种族差异和医院间变异。
研究设计与样本
- 回顾性队列研究,使用Premier Healthcare数据库,纳入2008至2018年间18岁以上全麻剖宫产患者130,946例。
主要发现
- osMMA使用率为8.5%(11,133例),从2008年2.0%增至2018年18.8%。
- 黑人种族使用osMMA为7.9% vs 9.3%(OR 0.87 [95%CI 0.81-0.94]),西班牙裔为8.6% vs 10.0%(OR 0.86 [95%CI 0.79-0.950]),均低于对应参照组。
- 子痫前期患者使用osMMA为9.0%(OR 0.91 [95%CI 0.85-0.98]),药物滥用史患者为12.5%(OR 1.42 [95%CI 1.27-1.58])。
- 医院间变异中等(ICC=38%)。
- OosMMA使用率为1.6%(2,122例),从2008年0.8%增至2018年4.1%。
关键数值与推荐
- osMMA定义为使用NSAIDs和对乙酰氨基酚(联用或不联用阿片类药物)且不使用阿片类复方制剂。
- OosMMA定义为在osMMA基础上加用局部麻醉技术(如躯干阻滞或局部麻醉浸润)。
临床怎么用
- 全麻剖宫产后应积极考虑阿片节省多模式镇痛,但需注意当前使用率低且存在差异。
- 临床实践中应关注种族和合并症(如子痫前期)对镇痛方案选择的影响。
局限性
- 回顾性研究设计可能存在混杂偏倚。
- 使用行政数据库,可能低估或错分镇痛措施。
- 仅纳入全麻剖宫产,结果不能推广至椎管内麻醉剖宫产。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Optimizing analgesia after cesarean delivery is essential to quality of patient recovery. The American Society of Anesthesiologists and the Society for Obstetric Anesthesia and Perinatology recommend multimodal analgesia (MMA). However, little is known about clinical implementation of these guidelines after cesarean delivery under general anesthesia (GA). We performed this study to describe the use of MMA after cesarean delivery under GA in the United States and determine factors associated with use of MMA, variation in analgesia practice across hospitals, and trends in MMA use over time. METHODS: A retrospective cohort study of women over 18 years who had a cesarean delivery under GA between 2008 and 2018 was conducted using the Premier Healthcare database (Premier Inc). The primary outcome was utilization of opioid-sparing MMA (osMMA), defined as receipt of nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen with or without opioids and without the use of an opioid-combination drug. Any use of either agent within a combination preparation was not considered osMMA. The secondary outcome was use of optimal opioid-sparing MMA (OosMMA), defined as use of a local anesthetic technique such as truncal block or local anesthetic infiltration in addition to osMMA. Mixed-effects logistic regression models were used to examine factors associated with use of osMMA, as well as variation across hospitals. RESULTS: A total of 130,946 patients were included in analysis. osMMA regimens were used in 11,133 patients (8.5%). Use of osMMA increased from 2.0% in 2008 to 18.8% in 2018. Black race (7.9% vs 9.3%; odds ratio [OR] [95% confidence interval {CI}] 0.87 [0.81-0.94]) and Hispanic ethnicity (8.6% vs 10.0%; OR, 0.86 [0.79-0.950]) were associated with less receipt of osMMA compared to White and non-Hispanic counterparts. Medical comorbidities were generally not associated with receipt of osMMA, although patients with preeclampsia were less likely to receive osMMA (9.0%; OR, 0.91 [0.85-0.98]), while those with a history of drug abuse (12.5%; OR, 1.42 [1.27-1.58]) were more likely to receive osMMA. There was moderate interhospital variability in the use of osMMA (intraclass correlation coefficient = 38%). OosMMA was used in 2122 (1.6%) patients, and utilization increased from 0.8% in 2008 to 4.1% in 2018. CONCLUSIONS: Variation in osMMA utilization was observed after cesarean delivery under GA in this cohort of US hospitals. While increasing trends in utilization of osMMA and OosMMA are encouraging, there is need for increased attention to postoperative analgesia practices after GA for cesarean delivery given low percentage of patients receiving osMMA and OosMMA.
引用
- Zanolli NC, Fuller ME, Krishnamoorthy V, et al. Opioid-Sparing Multimodal Analgesia Use After Cesarean Delivery Under General Anesthesia: A Retrospective Cohort Study in 729 US Hospitals. Anesth Analg. 2023. PMID: 36947464. doi:10.1213/ANE.0000000000006428
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。